Joseph M. Burnett - 29 Jun 2026 Form 4 Insider Report for ClearPoint Neuro, Inc. (CLPT)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
01 Jul 2026, 18:43:09 UTC
Prior SEC filing
22 Jun 2026
Next SEC filing
02 Jul 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Danilo D'Alessandro, by Power of Attorney for Joseph M. Burnett

Key filing fact

Joseph M. Burnett filed Form 4 for ClearPoint Neuro, Inc. (CLPT) on 01 Jul 2026.

Key facts

  • This page summarizes Joseph M. Burnett's Form 4 filing for ClearPoint Neuro, Inc. (CLPT).
  • 3 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 01 Jul 2026, 18:43.

Change

  • Previous filing in this sequence was filed on 22 Jun 2026.
  • Current net transaction value: -$387,600.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001721010 Primary reporting owner

BURNETT JOSEPH

Relationship
CEO and President, Director
Address
C/O CLEARPOINT NEURO, INC., 120 S. SIERRA AVE., SUITE 100, SOLANA BEACH
Signature
/s/ Danilo D'Alessandro, by Power of Attorney for Joseph M. Burnett
Signature date
01 Jul 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CLPT transaction

Common Stock

Options Exercise

Transaction value
Shares
+20,000
Change %
+17%
Price
$2.50*
Shares after
136,842
Date
29 Jun 2026
Ownership
Direct
Footnotes
F1
CLPT transaction

Common Stock

Sale

Transaction value
$387,600
Shares
-20,000
Change %
-15%
Price
$19.38
Shares after
116,842
Date
29 Jun 2026
Ownership
Direct
Footnotes
F1, F2
CLPT holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
191,388
Date
29 Jun 2026
Ownership
See Footnote
Footnotes
F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CLPT transaction Derivative

Stock Options (right to buy)

Options Exercise

Transaction value
Shares
-20,000
Change %
-7.4%
Price
$0.000000*
Shares after
250,000
Date
29 Jun 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
20,000
Exercise price
$2.50
Footnotes
F1, F4
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 4 footnotes

Footnote F1

The options exercised and sales reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on June 11, 2025 in accordance with Rule 10b5-1.

Footnote F2

Represents a weighted average sales price per share. The shares were sold at prices ranging from $19.15 to $19.54. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Footnote F3

These shares are owned directly by the Joseph M. Burnett Trust dated 10/20/2022 and indirectly by Joseph M. Burnett as trustee of the trust.

Footnote F4

The shares subject to this option vest as follows: (i) one-third of the total shares on the first anniversary of the grant date; and (ii) the remaining two-thirds of the total shares ratably on a quarterly basis over the 2-year period immediately following the first anniversary of the grant date. The grant date is November 7, 2017.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .